Clinical Trial: Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction in Subjects With Mixed

  • Low-density lipoprotein cholesterol (LDL-C) [ Time Frame: 8 weeks ]
  • Triglycerides (TG) [ Time Frame: 8 weeks ]


    • Original Primary Outcome: Same as current

    Current Secondary Outcome:

    • Total cholesterol [ Time Frame: 8 weeks ]
    • High-density lipoprotein cholesterol (HDL-C) [ Time Frame: 8 weeks ]
    • non-HDL-C [ Time Frame: 8 weeks ]
    • LDL-C/HDL-C ratio [ Time Frame: 8 weeks ]
    • C-reactive protein [ Time Frame: 8 weeks ]
    • Adverse events [ Time Frame: 4 and 8 weeks ]
    • Offset effect [ Time Frame: 2 weeks after withdrawal ]
      Offset effect of Pro-Omega LDL two weeks after withdrawal of placebo and Pro-Omega LDL on serum markers


    Original Secondary Outcome: Same as current

    Information By: Nordic Pharma, USA

    Dates:
    Date Received: February 20, 2014
    Date Started: February 2014
    Date Completion: July 2014
    Last Updated: December 10, 2015
    Last Verified: December 2015